ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China

25 3 月, 2026

One Min Read

10 Views

原文: https://finance.yahoo.com/sectors/healthcare/articles/immunitybio-inc-ibrx-announces-approval-145226136.html

Last Update: 25 3 月, 2026

Written By

Other Articles

Previous

Scotiabank Cuts PT on SailPoint, Inc. (SAIL) to $16 From $24 – Here’s Why

Next

Citi Updates Constellation Brands (STZ) to Buy From Neutral – Here’s Why

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept